RHOA and ovarian cancer: Chen et al. [67] found out that MUC16 and p120ctn were overexpressed in ovarian cancer patients and showed that the subcellular translocation of p120ctn was impacted by MUC16 through RhoA/Cdc42 activation in EOC.